Insights

Inventive step in Europe and the UPC

by Dr Paul England

Advocate General considers prescription support software to be a medical device

by Evelyne Friedel and Tasmina Goraya, PhD

Unjustified threats of patent infringement – changes to UK law

by Michael Washbrook

European Parliament adopts new medical device regulations

by Tasmina Goraya, PhD

Notified Bodies potentially liable to end users of medical devices rules CJEU

by multiple authors

Rezeptortyrosinkinase II: Patent protection for a test method does not extend to test results

by Dr. Dietrich Kamlah

Medicines and medical devices regulation post-Brexit

by Matthew Royle, Ph.D.

Pemetrexed in Germany: Federal Court of Justice sets aside decision of Appeal Court

by Christoph de Coster, LL.M. (UC Davis) and Julius Zacharias

Intellectual Property in the Life Sciences, in review

by Dr Paul England

Supreme Court ruling on penalty clauses: consequences for bad leaver provisions

by Debbie Cloake

Strategic considerations - why opt-out or why not?

by Dr. Anja Lunze, LL.M.

Using intellectual property protection

by Colin McCall